|
|
|
|
|
 |
|
 |
|
Company Name:
|
Corefront Corporation |
|
Address
|
Takeda Building 3F, 19 Sanei-chou,
Shinjuku-ku, Tokyo, Japan |
|
Mission
|
Our mission is to contribute to society by improving quality of human life through advanced technology. |
|
Company Exectives
|
| CEO: |
Kazuo Hatae |
| Director: |
Makoto Yoshida, PhD |
|
Haruo Ozaki, MD, PhD |
| Auditor: |
Teruyo Ozaki, MD |
| Adviser: |
Yasuhiro Hashimoto, MD (CEO of MediBic) |
|
Hikaru Kobayashi (Managing Director of MediBic) |
| Legal Adviser: |
Kenichi Senkawa (Attorney) |
|
|
Establishment:
|
October 1st, 1999 |
|
Capital:
|
61.2 million Yen |
|
Major Affiliated Bank
|
The Bank of Tokyo-Mitsubishi UFJ, Ltd.
SMBC Corporation
Seibu Trust Bank |
| Sales Volumes: |
120 Million Yen( Jan - Dec, 2003) |
|
Business fields:
|
Selling, manufacturing, importing, researching, and developing products in;
- Regenerative Medicine & Tissue Engineering
- Drug Discovery & Biotechnology
- Biomedical Instrument
- Optics Related Products
- Environmental Material |
|
|
|
|
Our history
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
